The effect of intranasal triamcinolone injection on the nasal polyp treatment & intraocular pressure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003127

Enrollment

Registered

2018-08-27

Start date

2017-11-14

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Nasal steroid injection is a slow application of 20 mg of TA (triamcinolone acetonide) diluted 1 mL to the nasal mucosa and the nasal mucosa using a 26 gauge spinal needle after shrinking the n

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Adults over 19 years - Recurring cost incidence after endoscopic sinus surgery

Exclusion criteria

Exclusion criteria: - Glaucoma - IOP =21 mmHg - High myopia (axial length> 26 mm or spherical equivalent <-6D) - connective tissue disease, diabetes, pregnancy, lactation

Design outcomes

Primary

Measure	Time frame
Check Nasal polyp size	—

Secondary

Measure	Time frame
Increase in intraocular pressure;Increase in intraocular pressure	—

Countries

Korea, Republic of

Contacts

Public ContactNam JungGwon

Ulsan Univeristy Hospital

jknam0266@naver.com+82-52-250-7180

Outcome results